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1. Introduction 
Rapid progress towards an understanding of the 
energetics of active transport of substrates across the 
cytoplasmic membrane of bacteria has been made 
using whole cells and derived vesicles [l-4], yet fur- 
ther insight into the mechanisms of active transport 
would be greatly facilitated by the isolation of solu- 
bilized transport proteins and their subsequent incor- 
poration into artificial lipid membranes. 
Much attention has focussed on the lactose ‘per- 
mease’ (Lacy, or M protein) of Escherichia coli, with 
recent publications highlighting its susceptibility to 
genetic manipulation [S-7] but relative intractability 
with regard to solubilization [8]. In an effort to gain 
parallel information on another membrane protein we 
have undertaken the identification of the galactose- 
specific transport system (GalP of E. coli [9-121, 
already demonstrated in this laboratory to function 
as a galactose-proton symporter [ 1 l-l 31 in accord- 
ance with the chemiosmotic theory [ 11. The epithet 
‘galactose-specific’ in historical [4,9], while its sub- 
strate specificity spans a range of hexoses including 
D-galactose, D-fucose and D-glucose, with the latter 
showing the best rates of transport [ 131. 
This report describes the identification, in a GalP 
constitutive strain, of a membrane protein which is 
Abbreviations: HEPES,N-2-hydroxyethylpiperazine-N’-2- 
ethanesulphonic acid; KP, potassium phosphate buffer, 
pH 6.6; NEM, N-ethylmaleimide; PMS, phenazine methosul- 
phate; SDS, sodium dodecyl sulphate; SDS-PAGE, sodium 
dodecyl sulphate polyacrylamide gel electrophoresis 
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specifically protected by glucose against inactivation 
by NEM. Its mobility under SDS-PAGE indicates an 
apparent MW of 34 000 f 1000 and it is tentatively 
identified as the GalP transport protein. 
2. Materials and methods 
E. coli strain S183-27T (mglB, mglC, mglD, lac 
(zya) deletion; MglP-, GalP constitutive), a kind gift 
of Dr B. Rotman, Brown University, Providence, 
RI 029 12, USA, was maintained and grown under 
conditions described previously [ 111, with additions 
of L-histidine, L-methionine, L-leucine and L-threo- 
nine to final concentrations of 90,80, 80 and 80 
pg/ml, respectively. Cells were harvested in late log 
phase after overnight growth on 20 mM glycerol as 
carbon source. Membrane vesicles were prepared as 
in [ 141 after preparing spheroplasts by the method 
in [ 151, and either used fresh, or frozen in liquid Nz 
and stored at -20°C prior to use; such frozen prepa- 
rations consistently showed only marginal lorses in 
transport activity when rapidly thawed at 37°C. 
Transport assays of GalP activity vesicles energized 
by ascorbate PMS followed the methods in [ 1 l] and 
[ 161, with manual sampling onto cellulose acetate 
filters (Oxoid, 0.45 pm pore size); 15 s time points 
were taken as comparative estimates of initial rates. 
Proteins were estimated in the presence of 0.5% 
SDS by the method in [ 171, using bovine serum 
albumin (Sigma, Fraction V) as standard. 
SDS-PAGE followed the method in [ 181, using 
slab gels comprising stacking and resolving gels of 
5% and 15% acrylamide plus 0.13% and 0.08% NN’- 
methylenebisacrylamide, respectively. After develop- 
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ment at a constant 75 V gels were futed and stained 
for 3 h, in each of the Coomassie solutions described 
in [ 191, destained in 10% acetic acid and finally per- 
fused with water; 0.1 cm wide slices (2 cm long, 
0.16 cm deep) were solubilized in sealed vial inserts 
overnight at 37’C in 40 ~130% w/v hydrogen perox- 
ide, and radioactivity counted as in [ 111. 
[ 14C]NEM, D-[ l-3H]galactose and D-[ 1-3H]fucose 
were purchased from The Radiochemical Centre, 
Amersham, UK; all other chemicals were of the 
highest grade commercially available. Dialysis tubing 
(Medicell, size l-8/32) was prepared for use as in 
[20]. Lysozyme, DNase and RNase were purchased 
from Sigma Chemical Co. 
3. Results 
In common with lactose transport [6,8,21] and 
several other systems [22-241, galactose transport 
was inactivated by the sulphydryl reagent NEM (fig.1). 
That the decrease in galactose uptake by NEM-treated 
vesicles was attributable to interaction at the trans- 
port site of GalP, and was not simply an impairment 
of the capacity ofvesicles to generate a proton motive 
force is indicated by the results in fig.2, where coun- 
terflux of the non-metabolizable GalP substrate fucose 
in whole cells was examined under conditions inde- 
pendent of respiration-driven transport [25]. The 
‘overshoot’ uptake of [3H] fucose was delayed by 
14 min in NEM treated whole cells; equilibrium was 
approached at much longer incubation times (not 
shown). This indicates that a proportion of the GalP 
sites have been inactivated by NEM in a similar man- 
ner to that described for Lacy [25]. In addition, it 
has been reported elsewhere that NEM does not 
affect the magnitude of the proton motive force 
generated in membrane vesicles oxidizing ascorbate- 
PMS [26]. 
Results of protection studies on GalP transport 
activity (table 1) reflected data established for its 
substrate specificity. Glucose, which is transported at 
least as rapidly as galactose [ 1 l] afforded significant 
protection to GalPin the presence of NEM; arabinose, 
which is not transported on GalP [ 1 l] offered little 
or no protection to inactivation. The apparent inhibi- 
tion of transport activity by glucose treatment on its 
own reflects the difficulty in reducing the concentra- 
tion of intra- and extravesicular glucose (added during 
protection) to levels which do not compete with 
subsequent energized accumulation of labelled galac- 
tose. 
The ability of glucose to protect GalP transport 
activity against NEM inactivation suggested that the 
transport protein might be identified by substrate 
protection during ‘cold’ NEM treatment followed by 
removal of the substrate and incubation with [ 14C]- 
NEM [21]. Using this strategy one would expect to 
find proportionally enhanced labelling in GalP com- 
pared with controls preincubated in the absence of 
protective substrates either with or without ‘cold’ 
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Fig.1. Time course for inactivation of GalP by NEM. Mem- 
brane vesicles in 0.1 M KP pH 6.6 were incubated at 25’C 
with (0) or without (0) 1 mM NEM. At the times indicated 
0.25 ml samples were quenched with 0.22 ml 10 mM mer- 
captoethanol and stored on ice until assayed for galactose 
transport. Quenched samples were then incubated at 25°C with 
stirring and gentle bubbling (compressed air), with 10 mM 
MgSO, final. After 2.5 min and 2.8 min, PMS and potassium 
ascorbate (pH 6.5) were added in sequence to final concen- 
trations of 0.1 mM and 20 mM, respectively. Transport was 
initiated by the addition of [‘H]galactose to a final concen- 
tration of 0.04 mM after 3 min incubation. 0.2 ml samples 
were withdrawn and faltered 15 s after addition of the labelled 
sugar, washed immediately with a total of 4 ml 0.1 M LiCl, 
and counted as in [ 111. Final protein concentration, 1.22 
mg/ml. 
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Fig.2 Inhibition of fucose counterflux in NEM-treated whole 
cells. S183-27T cells were harvested at dry mass 0.54 mg/ml, 
resuspended in 150 mM KCl, 5 mM HEPES, 30 mM sodium 
azide, pH 6.5 and incubated at 37°C for 1 h. Cells were again 
harvested, and resuspended in the above buffer to 1.92 mg/ml. 
1 .O ml aliquots of this suspension were incubated with (0) 
or without (0) 1 mM NEM at 25°C for 15 min; fucose was 
then added to each cell suspension to a final concentration 
of 20 mM, and left to equilibrate at 25’C for 30 min. Cells 
were harvested, resuspended in 1 .O ml 150 mM KCI, 5 mM 
HEPES,20 mMsodium azidepH 6.5 ~1~~0.5 mM [aH]fucose 
(6.25 ).&i/prnol) and uptakes of label assayed at 15’C, when 
0.1 ml samples were withdrawn, filtered, washed with fucose- 
free buffer at the times indicated, and counted as in [ 111. 
Table 1 
Substrate protection of GalP from inactivation by NEM 
Vesicle treatments GalP activity (nmol/mg Activrty % 
membrane protein/min) control 
Hz0 11.34 100 
NEM 1.42 12.5 
Glucose 6.64 58.6 
Glucose + NEM 3.24 28.6 
Arabinose + NEM 1.52 13.4 
Vesicle suspensions were pre-incubated at 25°C for 10 min 
with 50 mM sugar (or H,O), 10 mM MgSO, in 50 mM KP 
pH 6.6 prior to addition of NEM (1 mM final, as required; 
total reaction volume 1 .O ml). After a further 30 min at 25°C 
in the presence of NEM samples were transferred to ice, 
quenched by slow addition of 20 1~10.5 M mercaptoethanol 
and dialysed overnight against several changes in 50 mM KP 
pH 6.6,0-4°C (8 1 total). Samples were diluted with 0.2 ml 
buffer before carrying out duplicate energized assays at 25°C 
on 0.5 ml aliquots, as in fig.1. Final protein concentrations 
0.66 mg/ml 
NEM. Indeed such a procedure for [ 14C] NEM labelling 
of membrane vesicle proteins subsequently separated 
by SDS-PAGE revealed a single peak of proportion- 
ally enhanced labelling in samples which had received 
prior substrate protection (fig.3a,b; gel slices 50-52, 
MW range 33-35 000). In all other regions the pro- 
files for radioactive incorporation overlap closely, 
although there are slight discrepancies (1 to 3 gel 
slices) due to the difficulty in aligning different tracks 
precisely during slicing. The failure of ‘cold’ NEM to 
prevent completely the subsequent interaction of 
[ 14C]NEM with proteins at unprotected sites is inter- 
Fig.3. Relative enhancement of [ 14C]NEM labelling of vesicle membrane protein after substrate protection. (a) Vesicles (200 pg 
protein) were pre-incubated for 10 min at 25°C with 50 mM glucose (as required), 10 mM MgSO,, in 50 mM KP pH 6.6, prior to 
addition of NEM (1 mM final, as required; total reaction volumes 0.5 ml). After 30 min or 60 min further pre-incubation at 25°C 
free ‘cold’ NEM was removed by sedimenting and washing vesicles in 50 mM KP pH 6.6, 0-4OC. Vesicles were then resuspended 
in 1 mM [r4C]NEM, 50 mM KP pH 6.6 (7.3 mCi/mmol), incubated 60 min at 25’C before washing as above, and solubilization 
in dissolving buffer [ 181 by incubation at 100°C for 1 min. All sample loadings were 120 pg protein; one of the four identical gel 
tracks is shown adjacent o profiles of radioactivity. Preincubation conditions and total counts per track after subtraction of 
backgrounds: 60 min, 25°C no glucose, no NEM, 10 851 cpm (0); 60 min, 25”C, no ghrcose, 1 mM NEM, 2477 cpm (a); 60 min, 
25’~ 50 mM glucose, 1 mM NEM, 2848 cpm (A); 30 min, 25”C, 50 mM glucose, 1 mM NEM, 3990 cpm (0). (b) As in (a), but 280 pg 
protein initially. Samples olubilized at 60°C for 10 min, with 200 ng protein loaded per sample track. Preincubation treatments 
and legends as for [a), with total counts per profile after subtraction of all backgrounds in the order given for (a): 13 202 cpm; 
3893 cpm; 4387 cpm; 5537 cpm. The MW of [14C]NEM-labelled protein bands were estimated using the following protein 
markers: Bovine serum albumin 68 000; glutamate dehydrogenase, 56 000; ovalbumin, 43 000; lactate dehydrogenase, 35 500; 
carbonic anhydrase, 30 000; soyabean trypsin inhibitor, 21 000; ribonuclease, 14 000. The position of markers adjacent o each 
treatment is shown by the appropriate symbol on the lower axes. 
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preted as being due to the time dependence of the 
reaction. 
That these results are not an artifactual enhance- 
ment of labelled bands due to reduction in total 
[r4C]NEM incorporation (caused by prior incubation 
with ‘cold’ NEM) is indicated by the manner in which 
the profiles for samples pretreated without protective 
agent in the presence of ‘cold’ NEM (open triangles) 
match closely these for samples pre-incubated with 
neither ‘cold’ NEM nor substrate (open circles), 
despite a 2-3-fold difference in total counts. 
The peak showing enhanced labelling has an appar- 
ent MW close to that reported for one outer mem- 
brane protein of E. coli [27]. Fig.3b shows that iden- 
tical profiles were obtained under conditions where 
the outer membrane protein did not enter the gel 
matrix during electrophoresis (samples prepared by 
incubation in dissolving buffer at 60°C for 10 min, 
rather than 1OO’C for 1 min in fig.3a [27]), suggest- 
ing that this protein was not responsible for the 
enhanced labelling observed. 
4. Discussion 
There are seven systems known to be capable of 
transporting galactose in E. coli which must be con- 
sidered in interpreting the results reported here, i.e. 
GalP, MglP, AraE, AraF, Lacy, MelA and PtsG [28]. 
The lactose permease (Lacy) can be eliminated 
because the strain chosen has a Zac (zya) deletion; 
the melibiose (MelA) and arabinose transport systems 
(AraE and AraF) can also be disregarded since whole 
cells and vesicles of S 183-27T do not transport methyl 
P-D-thiogalactoside or arabinose [ 12,131. None of the 
respirationdriven uptake data reported in fig.1 or 
table 1 or the fluxes in fig.2 are consistent with MglP 
or PtsG transport activity; the strain is phenotypically 
MglP-negative, and the preparation of vesicles ensures 
loss of essential cytoplasmic phosphotransferase 
components or their poisoning in azide-treated whole 
cells. Yet protection by glucose membrane-bound 
MglP or PtsG components account for the results of 
fig.3, only if it is assumed that the demonstrated 
substrate protection of GalP (table 1) makes a negli- 
gible contribution to [ 14C]NEM incorporation. The 
transport data suggest hat it is GalP which is prefer- 
entially labelled by [ 14C] NEM after substrate protec- 
tion from ‘cold’ NEM. 
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